|
 |
Advair DiskusThis page contains recent news articles, when available, and an overview of Advair Diskus but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.This large prospective trial, which followed 475 patients who receivedeither twice-daily Advair Diskus 100/50 (fluticasone propionate and istockAnalyst.com, Advair Provides Benefits For African American Patients With Asthma - Jun 12, 2008 African American patients with asthma treated with Advair Diskus, a combination of the long-acting beta-agonist (LABA) salmeterol and the inhaled eMaxHealth.com, GSK's drug 'benefits' African American asthma patients - Jun 11, 2008 GlaxoSmithKline (GSK) has announced results from a study of its combination drug, Seretide/Advair Diskus, which show it has "important benefits" for African Hays Pharma, Asthma Drug Affects My Son’s Behavior - Jun 5, 2008 In fact the asthma drugs that people are concerned about are Advair Diskus, Advair HFA, Foradil Aerolizer, and Serevent Diskus. All these medications now Lawyers and Settlements Adding a LABA to ICS Also Decreased Risk of Asthma Exacerbations ... - Jun 2, 2008 Advair Diskus(R), a fixed-dose treatment, combines two medications in one device to help prevent and control asthma symptoms. Advair(R) contains both the PR Newswire (press release), The Effects of Fluticasone With or Without Salmeterol on Systemic ... - Jun 5, 2008 ...inhaled fluticasone (500 [mu]g twice daily) or inhaled fluticasone/salmeterol combination (500/50 [mu]g twice daily) (Advair Diskus; GlaxoSmithKline, RedOrbit, GlaxoSmithKline: No increase in cardiac events in patients treated ... - May 21, 2008 ...being treated with Advair Diskus 500/50 experienced the fewest adverse cardiac events compared with patients taking other treatments or a placebo. Forbes, What Led to the Black Box Warning on Asthma Drugs? - May 30, 2008 Washington, DC: Two years ago the US Food and Drug Administration (FDA) stated that the asthma drugs Advair Diskus, Advair HFA, Foradil Aerolizer, Lawyers and Settlements Advair Reduces Exacerbations In COPD Patients With A History Of ... - May 24, 2008 The use of Advair Diskus(R) 250/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a 30% reduction in exacerbations in patients with Medical News Today (press release), /CORRECTION -- GlaxoSmithKline/ - May 19, 2008 The randomized study of 797 patients was a replicate study which found that after a year of treatment, patients treated with Advair Diskus 250/50 had a 30% CNNMoney.com (press release) Asthma, Allergy Patients Respond Better To Advair - May 20, 2008 Patients with both asthma and allergic rhinitis, or seasonal allergies, experience significantly better lung function when treated with Advair Diskus eMaxHealth.com, Asthma Drugs: No Cause for Asthma Sufferers to Breathe Easy… - May 27, 2008 The manufacturers of Serevent Diskus, Advair Diskus and the Foradil Aerolizer have indicated that while it would take several months to gather the data, Lawyers and Settlements Advair superior to Singulair for asthma and allergies: study - May 20, 2008 New study results indicate that GSK's Advair Diskus is more effective than Merck's Singulair in patients suffering from asthma and seasonal allergies. Medical Marketing and Media, HMOs block key brand-name medicines to make big bucks, report says - May 18, 2008 ...for depression and anxiety, like Lexapro, prescriptions for diabetes, such as Actos and Avandia, and anti-asthmatics, like Singulair and Advair Diskus. New York Daily News, Update in Asthma 2007 - May 16, 2008 FDA public health advisory: Serevent, Diskus, Advair Diskus, Foradil Aerolizer [Internet]. 2005 Nov 18 [updated 2006 May 15, accessed 2008 Jan 7]. RedOrbit, Market Report -- In Play (WIRES) - May 19, 2008 ...or seasonal allergies, experience significantly better lung function when treated with GlaxoSmithKline's (GSK) Advair Diskus as compared with Singulair. MSN Money FDA Updates Safety Information for Long Acting Beta Agonists - Mar 6, 2008 On March 2, 2006, FDA approved new safety labeling and Medication Guides for patients for Serevent Diskus (salmeterol xinafoate) and Advair Diskus PharmaLive.com (press release), NY State Announces New Consumer Website To Help New Yorkers Find ... - Feb 14, 2008 In the Westchester region, Advair Diskus (dosage: 250 mg; quantity: 60), commonly prescribed for asthma treatment, was $193.62 at the lowest price and All American Patriots (press release), Less Inclined Towards glaxosmithkline - Nov 5, 2007 Moreover, the higher-strength version of Glaxo's inhaled Advair Diskus for chronic obstructive pulmonary disease has not been given final approval. Barron's GlaxoSmithKline's 500/50 strength of Advair Diskus in COPD not ... - Aug 8, 2007 ...a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation Forbes, GSK Supports Emphasis on Asthma Control and Use of Quick ... - Aug 29, 2007 Advair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. PR Newswire (press release), GSK says FDA declines to approve higher dose Advair - Aug 8, 2007 L: Quote, Profile, Research) said on Wednesday that US health regulators declined to approve a higher strength version of its inhaled Advair Diskus for the Reuters Glaxo's Advair Rejected by US FDA for an Added Use (Update2) - Aug 8, 2007 8 (Bloomberg) -- GlaxoSmithKline Plc failed to win US approval to market the strongest dose of the asthma inhaler Advair Diskus, the company's top-selling Bloomberg FDA Rejects New Use of Advair - Aug 8, 2007 AP 08.08.07, 12:06 PM ET Drug maker GlaxoSmithKline PLC said Wednesday government regulators rejected the company's request to allow its Advair Diskus drug Forbes, Pharma Sector: Few Newsmakers Of The Week - Wyeth, Glaxo, Active ... - Aug 12, 2007 British drug giant Glaxosmithkline's hopes to expand labeling for Advair Diskus, which is used to control asthma and chronic obstructive pulmonary disease, Trading Markets, GSK disppointment at FDA Advair decision - Aug 9, 2007 ...strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the treatment of chronic obstructive pulmonary disease (COPD). BiopharmaReporter.com, FDA Issues Not-Approvable Letter for Advair 500/50 in COPD - Aug 9, 2007 7 from the FDA for the use of Advair Diskus 500/50 to reduce exacerbations and increase survival in patients with chronic obstructive pulmonary disease FDA news (subscription), FDA turns down GlaxoSmithKline's Advair 500/50 for COPD - Aug 9, 2007 GlaxoSmithKline has been left stunned by a decision by US regulators to issue a ‘not approvable’ letter the highest dose of its asthma inhaler Advair Diskus Pharma Times (subscription), FDA rejects new use of Advair - Aug 8, 2007 AP - August 8, 2007 12:13 PM ET RESEARCH TRIANGLE PARK, NC - Government regulators have rejected a new use of GlaxoSmithKline's Advair Diskus drug in KJCT8.com, Business in Brief - Aug 8, 2007 ...(Reuters) GlaxoSmithKline has failed to win approval from the US Food and Drug Administration to market a higher-dose version of Advair Diskus, Times Online, FDA Rejects GSK Bid for New Dosage of Emphysema Drug - Aug 8, 2007 The FDA said no to a supplemental drug application for Advair Diskus, which is used to treat emphysema, or chronic obstructive pulmonary disease (COPD). Local Tech Wire, Alliant Techsystems Enters $2.8 Mln. Contract With Sandia National ... - Aug 8, 2007 ...of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease. RTT News, FDA Takes Caution on Approving New Drugs - Aug 17, 2007 Sanofi-Aventis' weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline's Advair Diskus for bronchitis and emphysema symptoms. The Associated Press MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of ... - Aug 10, 2007 Respiratory Inflammatory Disease development programs, as well as contributing to both Advair Diskus and Advair HFA New Drug Application submissions. PR Newswire (press release), Emerging trend hints at lower prescription drug prices - Jul 19, 2007 Medill Reports,Since hitting the market in the 1990s, brand names such as Zocor, Norvasc, Nexium, Advair Diskus, Lipitor and Plavix became household names, reaching $26.4 Reducing Asthma Treatment - Aug 1, 2007 New England Journal of Medicine (subscription),Serevent Diskus, Advair Diskus, and Foradil information (long acting beta agonists). Bethesda, MD: Department of Health and Human Services, 2006. Getting medication in privacy is part of Internet appeal, but ... - Jul 15, 2007 Sun-Sentinel.com,Other medications, in order of their ranking, that round out PharmacyChecker's top 10: the Advair diskus for asthma, Nexium for acid reflux, Vermont AG Announces Prescription Drug Price Finder Website - Jul 11, 2007 All American Patriots (press release),For the month of May 2007, the website indicates the following price disparities in Vermont: · Advair Diskus (for asthma): 60 doses of 250-50 mcgs range FDA Advisory Committee Finds Substantial Evidence To Support ... - May 8, 2007 Medical News Today (press release),An Advisory Committee to the US Food and Drug Administration (FDA) today unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50 FDA Advisory Committee Finds Substantial Evidence to Support ... - May 2, 2007 PharmaLive.com (press release),Advair Diskus(R) 250/50 was approved in 2003 for the maintenance treatment of airflow obstruction in patients with COPD associated with chronic bronchitis. Analysis: Asthma patients can cut dose - May 17, 2007 United Press InternationalThe researchers assigned 169 subjects to remain on that regimen, while assigning 165 patients to receive one daily dose of Advair Diskus (fluticasone plus FDA Advisory Committee Finds Substantial Evidence to Support ... - May 9, 2007 Pharmaceutical Processing,An Advisory Committee to the FDA recently unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50 (fluticasone propionate and salmeterol FDA panel not sure GSK's Advair increases COPD survival - May 2, 2007 Pharma Times (subscription),...view that the highest dose of its asthma blockbuster Advair Diskus can increase survival rates for patients with chronic obstructive pulmonary disease. FDA Advisory Committee Finds Substantial Evidence to Support ... - May 2, 2007 Compliance Home,...(May 1, 2007)-- An Advisory Committee to the US Food and Drug Administration (FDA) unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus(R) GlaxoSmithKline Receives Japanese Approval For Two Major New ... - Apr 23, 2007 Medical News Today (press release),GlaxoSmithKline (GSK) today announced that it has received approval for Seretide/Advair Diskus (salmeterol and fluticasone proprionate combination) and Japanese nod for GSK's Seretide/Advair and Arixtra - Apr 19, 2007 Pharma Times (subscription),GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the GlaxoSmithKline: Advair, Arixtra Receive Approval In Japan - Apr 18, 2007 Therapeutics Daily (subscription) (press release),LONDON (Dow Jones)--GlaxoSmithKline Wednesday announced that it has received approval for Seretide/Advair Diskus and Arixtra from the Ministry of Health, Glaxo gets marketing OK for Advair and Arixtra in Japan - Apr 18, 2007 Forbes,Seretide/Advair will be branded Advair Diskus, and has been approved for adult patients with bronchial asthma. Glaxo said it will be the only combination GlaxoSmithKline wins Japanese approval for bronchial asthma treatment - Apr 18, 2007 International Herald Tribune,LONDON: GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan. Doctors Say Treating Condition Requires the Right Medicine and the ... - Apr 16, 2007 LA Downtown News Online,In 2005, the Food and Drug Administration requested the manufacturers of Advair diskus, Foradil Aerolizer and Servent diskus update their product labels Beta-Agonists may cause thousands of asthma-related deaths each year - Jan 1, 2007 Health SentinelIn May 2005, the FDA requested manufacturers of these medications (Advair Diskus, Foradil Aerolizer, and Serevent Diskus) to update their product warning Combination Therapy Reduces COPD Exacerbations - Jan 15, 2007 MedPage Today,Among patients with severe COPD prone to frequent exacerbations, Advair Diskus 500/50 (fluticasone plus salmeterol) reduced these episodes by 35% compared GSK Submits Supplemental Drug Application for Advair in COPD Oct 11, 2006 GlaxoSmithKline announced today that it has submitted a supplemental new drug application to the FDA to expand labeling for Advair Diskus(R) (fluticasone ... -International News Service, Advair(R) HFA Inhalation Aerosol Now Available Oct 18, 2006 Advair(R), a medicine used in the treatment of asthma, became available in 2001 as a dry-powdered inhaler known as Advair Diskus (fluticasone propionate and ... -Medical News Today (press release), Advair(R) HFA Inhalation Aerosol Now Available Oct 17, 2006 New Metered-Dose Inhaler Allows Asthma Patients to Receive Benefits of Advair Diskus(R) in Alternative Device RESEARCH TRIANGLE PARK, NC, Oct. ... -PR Newswire (press release), Glaxo seeks permission to sell asthma drug Advair as treatment for ... Oct 11, 2006 North Carolina (AFX) - GlaxoSmithKline said it is seeking permission from the US Food and Drug Administration to market its asthma drug Advair Diskus as a ... -Forbes, GSK files for Advair as COPD therapy Oct 11, 2006 The company said the application is supported by data from the three-year TORCH study and other studies of the inhalable Advair Diskus (fluticasone propionate ... -United Press International GSK Submits SDA for Advair in COPD Oct 11, 2006 GlaxoSmithKline submitted a supplemental new drug application to expand labeling for Advair Diskus® (fluticasone propionate and salmeterol inhalation powder ... -Genetic Engineering News (press release), GlaxoSmithKline's (GSK) Advair HFA Inhalation Aerosol is Now ... Oct 17, 2006 ...nationwide. Advair, a medicine used in the treatment of asthma, became available in 2001 as a dry-powdered inhaler known as Advair Diskus. ... -StreetInsider.com (subscription), GSK rolls out new asthma inhaler Oct 17, 2006 Previously, Advair was only available in a dry-powder form called Advair Diskus, leaving some asthma patients unable to use the drug. ... -Bizjournals.com, GSK Submits Supplemental Drug Application For Advair Oct 11, 2006 GlaxoSmithKline PLC (GSK) submitted a supplemental new drug application to the Food and Drug Administration to market its Advair Diskus inhalation powder to ... -Therapeutics Daily (subscription) (press release), Glaxo launches new Advair inhaler in US Oct 17, 2006 The new device will be sold alongside Advair Diskus, the existing dry-powdered inhaler launched in the US in 2001, giving patients a second option for how they ... -Reuters Glaxo submits supplemental Advair request in US Oct 11, 2006 Plc (GSK.L: Quote, Profile, Research) said on Wednesday it has filed an application with US regulators to market its respiratory drug Advair Diskus as a ... -Reuters GlaxoSmithKline launches Advair HFA in US Oct 17, 2006 The dry-powdered form of the drug, which is known as Advair Diskus and was launched in the US in 2001, would be sold alongside Advair HFA. ... -newratings.com Blunt argument Oct 18, 2006 Alas, instead of puffing joints, I puff the Advair diskus, a flamboyantly purple asthma inhaler frequently, and ironically, advertised on the Oxygen channel. ... -Indiana Daily Student : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |